EARLY ALZHEIMERS DISEASE

Clinical trials for EARLY ALZHEIMERS DISEASE explained in plain language.

Never miss a new study

Get alerted when new EARLY ALZHEIMERS DISEASE trials appear

Sign up with your email to follow new studies for EARLY ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Could a probiotic slow Alzheimer's? new trial underway

Disease control Recruiting now

This study tests whether a probiotic called L. lactis CKDB001 is safe and can help slow memory and thinking decline in people with early Alzheimer's disease. About 60 adults aged 55 to 85 with mild symptoms and brain amyloid buildup will receive either the probiotic or a placebo …

Matched conditions: EARLY ALZHEIMERS DISEASE

Phase: NA • Sponsor: CKD Bio Corporation • Aim: Disease control

Last updated May 26, 2026 11:12 UTC

EARLY ALZHEIMERS DISEASE

Get alerted when new EARLY ALZHEIMERS DISEASE trials appear

Could a probiotic slow Alzheimer's? new trial underway